To explore a possible direct contribution of anti-tumour B cell responses to the observed association of TLS and B cell signatures with the survival of patients with LUAD, rather than this being a reflection of CD8+ T cell responses, we investigated B cell reactivity to TAAs. The gene discussed is CD8A; the disease is neoplasm.